{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:30:38Z","timestamp":1772641838186,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bcmd.2019.102395","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T05:59:04Z","timestamp":1575266344000},"page":"102395","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Concurrent chronic myeloid leukemia and CALR-mutated chronic myeloproliferative neoplasm"],"prefix":"10.1016","volume":"81","author":[{"given":"Francesca","family":"Guidotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Gardellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Feltri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Zancanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittoria","family":"Sacc\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Alberio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Ambrosiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Turrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcmd.2019.102395_bb0005","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/modpathol.2017.182","article-title":"Myeloproliferative neoplasms with concurrent BCR-ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group","volume":"31","author":"Soderquist","year":"2018","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.bcmd.2019.102395_bb0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.21037\/sci.2017.06.02","article-title":"CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report","volume":"23","author":"Dogliotti","year":"2017","journal-title":"Stem Cell Investig."},{"issue":"21","key":"10.1016\/j.bcmd.2019.102395_bb0015","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/blood-2015-03-632893","article-title":"Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1","volume":"125","author":"Loghavi","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcmd.2019.102395_bb0020","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00277-016-2827-3","article-title":"CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene","volume":"95","author":"Diamond","year":"2016","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.bcmd.2019.102395_bb0025","first-page":"1","article-title":"Coexistence of p190 BCR\/ABL transcript and CALR 52-bp deletion in chronic myeloid leukemia blast crisis: a case report","volume":"8","author":"Seghatoleslami","year":"2016","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"3","key":"10.1016\/j.bcmd.2019.102395_bb0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/ijlh.12798","article-title":"Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors","volume":"40","author":"Lewandowski","year":"2018","journal-title":"Int. J. Lab. Hematol."},{"issue":"11","key":"10.1016\/j.bcmd.2019.102395_bb0035","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s00277-018-3402-x","article-title":"The co-occurrence of driver mutations in chronic myeloproliferative neoplasms","volume":"97","author":"Boddu","year":"2018","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.bcmd.2019.102395_bb0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ajh.25249","article-title":"Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation","volume":"94","author":"Xia","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"14","key":"10.1016\/j.bcmd.2019.102395_bb5000","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/blood-2014-12-616847","article-title":"CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation","volume":"125","author":"Bonzheim","year":"2015","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcmd.2019.102395_bb5005","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMc1413718","article-title":"A CALR mutation preceding BCR-ABL1 in an atypical myeloproliferative neoplasm","volume":"372","author":"Cabagnols","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979619304449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979619304449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:34:05Z","timestamp":1761050045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979619304449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":10,"alternative-id":["S1079979619304449"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2019.102395","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concurrent chronic myeloid leukemia and CALR-mutated chronic myeloproliferative neoplasm","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2019.102395","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102395"}}